During our short time in Handheld Mode, Capcom convinced us the Switch 2 looks ready to handle the next chapter in its flagship horror series.

The Fox News train, driven by Jesse Watters, kept rolling between July and September, with the right-leaning channel dominating its cable rivals and beating ABC and CBS in weekday primetime viewership ...

The morning news shows started off the 2025-2026 broadcast season with good news for NBC's Today for the week of September 22. NBC News' Today overtook ABC News' Good Morning America to become the ...

Marvel Cosmic Invasion may not have a release date yet, but it does have a demo. The coolest-looking Marvel game in years, and a game many of us at Kotaku are excited to play later this year, now has ...

FOX News Channel averaged 3.3 million weekday primetime viewers through September 2025, beating broadcast networks CBS, ABC and NBC for the year.

The standout feature is “cameos,” where users can place a realistic avatar of themselves in any generated clip.

Exclusive: We sit down with the director of the Final Fantasy VII Remake trilogy to chat about bringing modern FF to the Nintendo Switch 2. He's ready to prove the naysayers wrong.

OpenAI’s Sora 2 is a video-and-audio AI model paired with the new Sora app. Here’s a complete guide to what it does, how to try it, and the catches you should know about.

Contrary to what many believe, you don’t need a huge bankroll to trade big. There are smarter ways to get there. FundedPrime offers one of them: pay a small entry fee, prove you can trade within their ...

Oliver Fire Department spokesperson Rob Graham said their crews were called out to the intersection of Highway 97 and Road 1 for a crash involving the fire truck with one vehicle that had been ...

Bengaluru will host Anthropic’s first developer event in India on October 11, in partnership with Accel. The invite-only AI Dev Day will bring together CTOs, product leaders, and founders to explore ...

Purpose Sotatercept, an activin signalling inhibitor approved in March 2024 for pulmonary arterial hypertension (PAH), demonstrated efficacy in clinical trials. This pharmacovigilance study evaluated ...